A case of Graves' ophthalmopathy associated with pembrolizumab (Keytruda) therapy

Ella S.Y. Park; Guilherme Rabinowits; Ole-Petter R. Hamnvik; Linda R. Dagi

doi:10.1016/j.jaapos.2018.01.006

A case of Graves' ophthalmopathy associated with pembrolizumab (Keytruda) therapy

Ella S.Y. Park
, Guilherme Rabinowits
, Ole-Petter R. Hamnvik
, Linda R. Dagi

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of AAPOS
DOIs	https://doi.org/10.1016/j.jaapos.2018.01.006
State	Published - Apr 1 2018
Externally published	Yes

Disciplines

Medicine and Health Sciences
Surgery

Access to Document

10.1016/j.jaapos.2018.01.006License: Unspecified

Cite this

@article{0814208416f647209b4cc8201ef8e9a9,

title = "A case of Graves' ophthalmopathy associated with pembrolizumab (Keytruda) therapy",

author = "Park, \{Ella S.Y.\} and Guilherme Rabinowits and Hamnvik, \{Ole-Petter R.\} and Dagi, \{Linda R.\}",

note = "We present the first reported case of Graves' orbitopathy induced by pembrolizumab, a new FDA-approved drug used for the treatment of multiple refract...",

year = "2018",

month = apr,

day = "1",

doi = "10.1016/j.jaapos.2018.01.006",

language = "American English",

journal = "Journal of AAPOS",

}

TY - JOUR

T1 - A case of Graves' ophthalmopathy associated with pembrolizumab (Keytruda) therapy

AU - Park, Ella S.Y.

AU - Rabinowits, Guilherme

AU - Hamnvik, Ole-Petter R.

AU - Dagi, Linda R.

N1 - We present the first reported case of Graves' orbitopathy induced by pembrolizumab, a new FDA-approved drug used for the treatment of multiple refract...

PY - 2018/4/1

Y1 - 2018/4/1

UR - https://www.sciencedirect.com/science/article/pii/S1091853118300399

U2 - 10.1016/j.jaapos.2018.01.006

DO - 10.1016/j.jaapos.2018.01.006

M3 - Article

JO - Journal of AAPOS

JF - Journal of AAPOS

ER -

A case of Graves' ophthalmopathy associated with pembrolizumab (Keytruda) therapy

Disciplines

Access to Document

Other files and links

Cite this